[go: up one dir, main page]

BRPI0800601A2 - dose-booster vaccination method for malaria using recombinant viruses and vaccine composition - Google Patents

dose-booster vaccination method for malaria using recombinant viruses and vaccine composition

Info

Publication number
BRPI0800601A2
BRPI0800601A2 BRPI0800601-6A BRPI0800601A BRPI0800601A2 BR PI0800601 A2 BRPI0800601 A2 BR PI0800601A2 BR PI0800601 A BRPI0800601 A BR PI0800601A BR PI0800601 A2 BRPI0800601 A2 BR PI0800601A2
Authority
BR
Brazil
Prior art keywords
malaria
dose
vaccination method
recombinant viruses
vaccine composition
Prior art date
Application number
BRPI0800601-6A
Other languages
Portuguese (pt)
Inventor
Ricardo Tostes Gazzinelli
Oscar Bruna-Romero
Bruna De Andrade Pereira
Original Assignee
Univ Minas Gerais
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minas Gerais filed Critical Univ Minas Gerais
Priority to BRPI0800601-6A priority Critical patent/BRPI0800601A2/en
Publication of BRPI0800601A2 publication Critical patent/BRPI0800601A2/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

MéTODO DE VACINAçãO DOSE-REFORçO PARA MALáRIA QUE UTILIZA VìRUS RECOMBINANTES E COM POSIçãO VACINAL. A presente invenção diz respeito a um método de vacinação dose-reforço (prime-boost) que utiliza vetores adenovirais, poxvirais e proteínas purificadas para imunização de mamíferos contra malária. Além disso, a presente invenção diz respeito a composições vacinais úteis para serem utilizadas como vacina contra malária. amente aceitáveis.DOSE-REINFORCEMENT VACCINATION METHOD FOR VACINAL POSITIONING RECOMBINANT VIRUSES. The present invention relates to a prime-boost vaccination method utilizing adenoviral, poxviral vectors and purified proteins for mammalian immunization against malaria. In addition, the present invention relates to vaccine compositions useful for use as a malaria vaccine. acceptable.

BRPI0800601-6A 2008-01-31 2008-01-31 dose-booster vaccination method for malaria using recombinant viruses and vaccine composition BRPI0800601A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0800601-6A BRPI0800601A2 (en) 2008-01-31 2008-01-31 dose-booster vaccination method for malaria using recombinant viruses and vaccine composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0800601-6A BRPI0800601A2 (en) 2008-01-31 2008-01-31 dose-booster vaccination method for malaria using recombinant viruses and vaccine composition

Publications (1)

Publication Number Publication Date
BRPI0800601A2 true BRPI0800601A2 (en) 2009-09-22

Family

ID=41077878

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0800601-6A BRPI0800601A2 (en) 2008-01-31 2008-01-31 dose-booster vaccination method for malaria using recombinant viruses and vaccine composition

Country Status (1)

Country Link
BR (1) BRPI0800601A2 (en)

Similar Documents

Publication Publication Date Title
EA201591888A1 (en) REPLICATION-DEFECT VACCINES AND VACCINE VECTORS AGAINST FLAVIVIRUSS
MX2021006342A (en) Influenza virus mutants and uses therefor.
NO20090194L (en) Recombinant viral vaccine
WO2010019262A3 (en) Polyvalent vaccine
BR112014024612A2 (en) nucleic acid, polypeptide, glycoprotein and chimeric, dengue virus epitope, chimeric flavivirus-like particle (vlp), chimeric flavivirus, and in vitro methods to identify a neutralizing antibody and to identify an immunogenic composition against a dengue virus
BR112014008694A2 (en) recombinant polycistronic nucleic acid molecules
BR112012004698A2 (en) methods for reducing virucidal activity in pcv-2 compositions and pcv-2 compositions with improved immunonugenicity.
MX2010008799A (en) Process for stabilizing an adjuvant containing vaccine composition.
MX359257B (en) Prostate-associated antigens and vaccine-based immunotherapy regimens.
BRPI1007721B1 (en) vaccine composition for use in inducing an immune response against a rotavirus in an individual, a rotavirus strain isolated from cdc-9 and a rotavirus strain isolated from cdc-66
MX344015B (en) VACCINES AND DIAGNOSIS FOR TORQUE TENO VIRUS PORCINO.
EA201391515A1 (en) INACTIVATED DENGE VIRUS VACCINE
BR112015001313A2 (en) vaccine compositions
BR112015002131A8 (en) RECOMBINANT VACCINIA ANKARA VIRUS (MVA), PHARMACEUTICAL COMPOSITION AND USE OF SUCH RECOMBINANT MVA
MX362977B (en) Vectors for transforming mycoplasma hyopneumoniae, transformed m. hyopneumoniae strains, and use thereof.
UY33297A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A POLYPEPTIDE THAT UNDERSTANDS AT LEAST A CXXC REASON AND HETEROLOGICAL ANTIGENS AND USES OF THE SAME
CY1120430T1 (en) RECOMMENDED CDV COMPOSITIONS AND USES OF THESE
AU2011280259A8 (en) Influenza vaccine
MX2016001695A (en) Combination immunogenic compositions.
BR112012022939A2 (en) pharmaceutical composition for use in a method of immunizing an individual in need thereof against an influenza virus
FI20115374A0 (en) New hypoallergens
CO6670515A2 (en) Parapoxvirus Vectors
MX2013000787A (en) PARAPOXVIRUS VECTORS.
BRPI0800485B8 (en) recombinant viral vectors, leishmaniasis vaccine composition and leishmaniasis vaccination method
MA32305B1 (en) Inactivated attenuated live virus vaccine for bluetongue

Legal Events

Date Code Title Description
B03A Publication of an application: publication of a patent application or of a certificate of addition of invention
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07D Technical examination (opinion) related to article 229 of industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal
B09B Decision: refusal

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL